Basic Levitra With Dapoxetine Information

• INN (International Nonproprietary Name): Vardenafil with Dapoxetine — Vardenafil for erectile dysfunction (ED) and Dapoxetine for premature ejaculation (PE).
• Brand Names Available In Canada (English): Super Levitra; Levitra With Dapoxetine; Vardenafil+Dapoxetine; Super Vilitra — note that these are international brand names commonly seen via import and online pharmacies.
• ATC Code: Vardenafil G04BE09; Dapoxetine G04BX14; both fall under ATC G04 (Urologicals).
• Forms & Dosages: Film-coated tablets in 20 mg Vardenafil/60 mg Dapoxetine and 40 mg Vardenafil/60 mg Dapoxetine strengths, commonly packed in blisters of 4, 10, or 20 tablets.
• Manufacturers In Canada (English): not specified.
• Registration Status In Canada (English): not specified.
• OTC / Rx Classification: Prescription-only (Rx) in most jurisdictions; not available OTC.

Latest Research Highlights

Patients often ask whether combining a PDE5 inhibitor with an on-demand SSRI adds meaningful benefit for men with both ED and PE.

International trials between 2022 and 2025 examined combinations of vardenafil with dapoxetine and found additive clinical benefits in dual-diagnosis patients.

Meta-analyses reported that vardenafil primarily improves erectile rigidity while dapoxetine shortens intravaginal ejaculatory latency when taken on demand.

Pooled results favour combination therapy over monotherapy for men with coexisting ED and PE but also show higher rates of transient adverse events such as headache, dizziness and nausea.

Canadian randomised controlled trial data for fixed-dose vardenafil with dapoxetine are sparse, and most Canadian clinicians reference international trials and observational registries.

Research gaps include a lack of Health Canada–sponsored trials and limited long‑term safety data for fixed-dose combinations, especially in older adults with cardiovascular comorbidity.

Data Highlight: Pooled effect sizes favour combination therapy over monotherapy for dual diagnoses; exact effect sizes and NNT/NNH are not specified in available pooled summaries.

Patient Note: Canadian clinicians balance these international data with equity and safety concerns for rural patients who may access care by telehealth.

Clinical Effectiveness In Canada

Clinicians frequently want to know whether international efficacy translates to Canadian practice.

There is no Health Canada–authorised fixed‑dose vardenafil with dapoxetine product listed with a DIN, so clinicians extrapolate from separate data for vardenafil and dapoxetine.

Real‑world Canadian practice reports patient‑reported improvements in erectile function and ejaculatory control when both mechanisms are targeted in men with mixed ED/PE.

Effectiveness in practice is moderated by cardiovascular disease, polypharmacy and advancing age.

• IIEF: International Index of Erectile Function — measures erectile domains and overall sexual function.
• IELT: Intravaginal Ejaculatory Latency Time — stopwatch or patient estimate for ejaculatory latency.
• Patient Satisfaction: Subjective outcome commonly used in clinical follow‑up.

Health policy consequences of no DIN for the fixed combination mean provincial formularies such as Ontario Drug Benefit, BC PharmaCare and RAMQ typically do not list the combo.

Coverage decisions therefore focus on individual agents that have DINs, and community pharmacists at Shoppers Drug Mart, Rexall, Jean Coutu and London Drugs frequently counsel patients on sourcing and risks.

Standard on‑demand dosing is one tablet containing 20 mg/60 mg taken 30–60 minutes before intercourse, with a maximum of one tablet per 24 hours.

Indications And Expanded Uses

Patients commonly ask, “Who is this combination intended for?”

The primary indication is symptomatic management of erectile dysfunction and premature ejaculation in men diagnosed with both conditions.

In Canada the fixed‑dose combination is not Health Canada‑authorised, so prescribing usually involves separate agents or off‑label use of importable fixed combinations from markets where they are sold.

Expanded or off‑label uses seen internationally include men with severe performance anxiety or patients intolerant to daily SSRIs, but these uses should only occur under specialist oversight.

The combination is contraindicated in adolescents and in men with unstable cardiac disease.

• Approved Single-Agent Uses: Vardenafil for ED; Dapoxetine for PE (where available as single agent).
• Off‑Label/Combo Practices: Imported fixed combinations for dual diagnosis or separate prescribing of vardenafil plus dapoxetine.

Patient‑Centred Note: Provide bilingual informed consent (English/French) and culturally sensitive sexual health counselling for Indigenous and immigrant communities where stigma may affect uptake.

Rural patients may prefer telemedicine consultations, and pharmacists in remote communities must follow provincial dispensing rules when handling off‑label imports.

Dosing guidance: take 30–60 minutes prior to intercourse; do not exceed one tablet per 24 hours.

Composition And Brand Landscape

People often want to see the ingredients and who makes these products.

Each tablet combines vardenafil, a PDE5 inhibitor, with dapoxetine, a short‑acting SSRI‑like agent for premature ejaculation.

Market names include Super Levitra, Super Vilitra and other labels that list the strengths such as 20 mg/60 mg or 40 mg/60 mg.

Typical pack sizes are film‑coated tablet blisters of 4, 10 or 20 tablets and packaging is commonly labelled with both strengths.

Canadian Context: There is no Canadian‑origin fixed combination with a DIN.

Pharmacies such as Shoppers Drug Mart, Rexall, Jean Coutu and London Drugs will typically encounter imported supplies via online pharmacies rather than domestic stock.

Imported packs that lack bilingual English/French labelling raise regulatory and counselling flags for pharmacists.

Patient Safety Tip: Verify batch number, expiry and authenticity before dispensing and document the supplier and batch in the patient’s record.

Contraindications And Special Precautions

Safety is the first question clinicians and patients ask.

Absolute contraindications include known hypersensitivity to vardenafil or dapoxetine and concurrent nitrate therapy due to the risk of severe hypotension.

Other absolute exclusions are recent myocardial infarction or stroke, severe heart failure, moderate to severe hepatic or renal impairment and age under 18.

Concurrent use with SSRIs, MAOIs or thioridazine is also an absolute contraindication.

• Relative Contraindications: Uncontrolled hypertension, bleeding disorders, predisposition to priapism (for example sickle cell), significant psychiatric history.
• Medication Interactions: Alpha‑blockers and strong CYP3A4 inhibitors require close monitoring.

Life‑Threatening Interaction Alert: Nitrates plus any PDE5 inhibitor can cause profound hypotension and is a contraindication to combined use.

Canadian Nuance: Prescribers should document a cardiovascular risk assessment consistent with Canadian Cardiovascular Society guidance and check provincial records when available.

Special Populations: Elderly patients and Indigenous communities with higher burdens of comorbidity require closer monitoring and culturally safe counselling.

Alcohol Use: Counsel patients that combining dapoxetine with alcohol increases the risk of dizziness and syncope.

Pharmacy Practice: Pharmacists in major chains should flag non‑DIN imports and contact prescribers for clinical justification before dispensing.

Dosage Guidelines

One of the most common practical questions is, “How should I take it?”

Standard on‑demand dosing is one tablet containing 20 mg vardenafil plus 60 mg dapoxetine (or 40 mg/60 mg variants), taken 30–60 minutes before sexual activity, not to exceed one tablet per 24 hours.

This combination is not intended for continuous daily use.

Start at the lowest effective dose in elderly patients and those with comorbidities.

Definition: “On‑demand” means taken only before anticipated sexual activity rather than daily chronic dosing.

Canadian Practice Note: With no Health Canada‑approved fixed combo, clinicians may prescribe separate DIN‑listed vardenafil and arrange access to dapoxetine via importation or off‑label pathways; document decisions in the chart for formulary audits.

Monitoring: Record baseline blood pressure and concurrent medications such as alpha‑blockers and CYP3A4 inhibitors before first dispense.

Missed Dose: Skip and wait for next planned sexual activity; do not double up.

Overdose: Seek urgent medical attention for symptoms such as severe hypotension or signs of serotonin syndrome.

Interactions Overview

Drug interactions are a frequent focus in consultations.

Major contraindicated interactions include nitrates, which can cause severe hypotension with any PDE5 inhibitor.

Strong CYP3A4 inhibitors such as ketoconazole and clarithromycin can raise vardenafil levels and increase adverse effects.

Concurrent SSRIs, MAOIs or thioridazine increase the risk of serotonin syndrome with dapoxetine and are contraindicated.

Alpha‑blockers may produce additive hypotension and require careful dosing and monitoring.

• Common Lifestyle Interactions: Alcohol increases dizziness and syncope risk when combined with dapoxetine.
• Grapefruit Juice: May inhibit CYP3A4 and raise PDE5 inhibitor levels; advise avoidance shortly around dosing.

Interaction Severity: Contraindicated combinations (nitrates, MAOIs) must never be used; other combinations require dose adjustment or monitoring.

Clinical Workflow: Pharmacists at Shoppers Drug Mart, Rexall and other community outlets should run provincial e‑systems and MedsCheck‑style reviews for interacting prescriptions.

Cross‑Border Purchases: Warn patients who procure US generics or online imports about unlabelled excipients and interaction risks.

Adverse Event Reporting: Report serious suspected interactions to Canada Vigilance.

Patient Counselling: Provide bilingual interaction sheets and advise rural patients to bring a full medication list to every appointment.

Cultural Perceptions And Patient Habits

Many patients hesitate to talk about sexual health because of privacy concerns and stigma.

Stigma tends to be stronger among older generations, some Indigenous communities and certain immigrant groups, which can delay care.

Urban patients are more likely to visit sexual health clinics or urologists, while rural patients rely more on family physicians and pharmacists.

Online forums show interest in combination therapy for convenience and concerns about cross‑border pricing and safety when sourcing online.

• Patient Concerns: Privacy, cost, access, bilingual resources and authenticity of online purchases.
• Practical Habits: Many men prefer on‑demand dosing; some try to self‑source via online pharmacies which increases safety risk.

Cultural Adaptation: Use bilingual educational materials and culturally safe counselling for Indigenous patients.

Pharmacy Tip: Community pharmacies with private consultation rooms such as Jean Coutu and Shoppers Drug Mart can normalise these conversations and provide MedsCheck reviews.

Common Side Effects Patients Report: Headache, flushing, dizziness, insomnia and anxiety/restlessness related to the dapoxetine component.

Availability And Pricing Patterns

Availability varies by market and regulatory status.

Fixed‑dose vardenafil with dapoxetine tablets are commonly marketed in India and some Asian markets and appear on international e‑pharmacies as Super Vilitra or Super Levitra, but they lack widespread Health Canada authorisation.

Canadian retail chains usually stock DIN‑listed single‑agent PDE5 inhibitors and will not routinely carry non‑DIN imported combos.

Online Canadian pharmacies may facilitate special importation under patient‑specific exemption policies, but caution is advised.

Pricing Notes: Provincial drug plans rarely cover sexual dysfunction medications except in exceptional circumstances.

Cross‑Border Caution: Lower US prices are offset by regulatory and labelling differences — imported packs may lack bilingual labels and have different excipients.

Rural Patients: Shipping costs and limited local stock increase total cost and reduce ability to inspect products in person.

Pharmacist Actions: Document source, advise storage below 30°C, and counsel patients on counterfeit risk.

Purchase Context: In our online pharmacy, levitra with dapoxetine is available without a prescription, with discreet delivery to Canada (English) in 5‑14 days.

Comparable Medicines And Preferences

Patients often want alternatives that are locally available and supported by Canadian formularies.

Alternative single‑agent PDE5 inhibitors in Canada include vardenafil (Levitra), sildenafil (Viagra) and tadalafil (Cialis).

Dapoxetine is sold as Priligy in markets where it is available as a single agent, and other international fixed combos include sildenafil plus dapoxetine (Super P‑Force).

Choice Drivers: Onset time, duration, side effect profile, cost and formulary coverage are the main factors guiding selection.

For men prioritising spontaneity, tadalafil’s longer window may be preferred, while combined ED/PE cases often require simultaneous targeting of both mechanisms with separate agents if a fixed combo is not available domestically.

Pharmacist Checklist: Review pros and cons, monitor for interactions and ensure bilingual counselling and appropriate mail‑order policies for rural patients.

FAQ Section

Q: Is Levitra with Dapoxetine approved in Canada?

A: As of the latest reviews there is no Health Canada approval or DIN for a fixed‑dose vardenafil with dapoxetine product; clinicians may prescribe separate agents or use special importation pathways.

Q: Can I get it at Shoppers Drug Mart or Rexall?

A: Pharmacies typically dispense DIN‑listed single agents; imported combos are not routinely stocked — ask your pharmacist for sourcing options and safety checks.

Q: Is it covered by provincial plans?

A: Unlikely; Ontario Drug Benefit, BC PharmaCare and RAMQ generally do not list sexual dysfunction combinations unless exceptional criteria apply.

Q: What are the common side effects?

A: Headache, flushing, dizziness, nausea, insomnia and anxiety/restlessness are common; serious risks include hypotension and serotonin syndrome.

Q: Is buying online safe?

A: There is risk — verify that the seller is a licenced Canadian pharmacy, check batch authenticity and ensure bilingual labelling when possible.

Urgent Red Flag: Never combine this product with nitrates due to risk of severe hypotension.

Storage Reminder: Store below 30°C and keep in original packaging; do not exceed one tablet per 24 hours.

Guidelines For Proper Use

Clinicians and pharmacists need a clear checklist for safe initiation and monitoring.

Confirm dual diagnosis using validated questionnaires such as the IIEF and an estimation of IELT before initiating therapy.

Perform a cardiovascular risk assessment in line with Canadian Society of Cardiology guidance before prescribing any PDE5 inhibitor.

Review the full medication list for contraindicated drugs such as nitrates, SSRIs, MAOIs, thioridazine, alpha‑blockers and strong CYP3A4 inhibitors.

1. Prefer DIN‑listed single agents where possible and document the clinical rationale for combination therapy.
2. If importing a fixed combination, obtain informed consent, record the supplier and batch details, and provide bilingual counselling.
3. Provide clear dosing instructions: take one tablet 30–60 minutes prior to sexual activity and do not exceed one per 24 hours.
4. Perform MedsCheck or equivalent review and report any serious adverse events to Canada Vigilance.

Provincial Tips: Check ODB, PharmaCare and RAMQ exception processes before dispensing and use telehealth for rural follow‑up when required.

Emphasise that initiation must occur under medical supervision and that recreational use or sharing of medication is unsafe.

Absolute contraindications to reiterate: concurrent nitrates and moderate to severe hepatic or renal impairment.

Delivery Across Canada (English)